Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 720,767 shares.
Evofem Biosciences Stock Down 4.3 %
The stock has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01. The company has a market capitalization of $1.02 million, a price-to-earnings ratio of -0.01 and a beta of -0.87.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Articles
- Five stocks we like better than Evofem Biosciences
- Using the MarketBeat Dividend Yield Calculator
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is MarketRank™? How to Use it
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- The Most Important Warren Buffett Stock for Investors: His Own
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
